Are patients with elevated liver tests at increased risk of drug-induced liver injury?
- 1 May 2004
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 126 (5), 1477-1480
- https://doi.org/10.1053/j.gastro.2004.03.030
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Patients with elevated liver enzymes are not at higher risk for statin hepatotoxicityGastroenterology, 2004
- How to use statins in patients with chronic liver disease.Cleveland Clinic Journal of Medicine, 2004
- The Safety of Valproic Acid Use for Patients With Hepatitis C InfectionAmerican Journal of Psychiatry, 2003
- Incidence of and Risk Factors for Severe Hepatotoxicity Associated with Antiretroviral Combination TherapyThe Journal of Infectious Diseases, 2002
- Prevalence and interaction of hepatitis B and latent tuberculosis in Vietnamese immigrants to the United StatesAmerican Journal of Gastroenterology, 2002
- Isoniazid Preventive Therapy, Hepatitis C Virus Infection, and Hepatotoxicity among Injection Drug Users Infected withMycobacterium tuberculosisClinical Infectious Diseases, 2001
- Hepatitis B and C virus co-infection and the risk for hepatotoxicity of highly active antiretroviral therapy in HIV-1 infectionAIDS, 2000
- Hepatotoxicity Associated With Antiretroviral Therapy in Adults Infected With Human Immunodeficiency Virus and the Role of Hepatitis C or B Virus InfectionJAMA, 2000
- Antituberculosis Drug–induced HepatotoxicityAmerican Journal of Respiratory and Critical Care Medicine, 1998
- Isoniazid-rifampin-induced hepatitis in hepatitis B carriersGastroenterology, 1990